ArticleWorld journal of gastroenterology2025
Factors influencing diagnostic delays in celiac disease.
Article in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Mass Screening Strategies for Celiac Disease in Apparently Healthy Children and Adolescents: A Systematic Review.Medicina (Kaunas, Lithuania) · 2026Pooled it
- Quality of Life and Gluten-Free Diet Adherence in Adult Patients with Celiac Disease: A Cross-Sectional Questionnaire Study.Nutrients · 2026Article
- Recent advances in the diagnosis of celiac disease.World journal of gastroenterology · 2025Article
- Gluten-related nutritional challenges in pediatric subjects: treatment and beyond.Frontiers in nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCeliac disease (CeD), an autoimmune disorder triggered by gluten ingestion, is characterized by non-specific clinical manifestations such as fatigue, abdominal pain, and nutritional deficiencies, often leading to substantial diagnostic delays. Prolonged delays (≥ 2 years from symptom onset) are associated with increased risks of complications like osteoporosis, small intestinal lymphoma, and reduced quality of life.
aimTo estimate diagnostic delay prevalence and identify risk factors in Chinese CeD patients.
methodsWe reviewed clinical records of 166 patients diagnosed with CeD from 2017 onward. Patient-attributed delays were measured from symptom onset to first consultation, while physician-related delays were measured from initial visit to diagnosis/treatment. Data on demographics, symptoms, time from onset to diagnosis, and laboratory results were analyzed. Logistic regression models were used to identify associations, while restricted cubic splines explored nonlinearities. Mediation analysis assessed the roles of intermediate factors in delayed diagnosis.
resultsDelayed diagnosis (over 2 years from symptom onset) was observed in 42.2% of patients. Patients with diagnostic delay exceeding 5 years accounted for 18.7%. The mean interval from symptom onset to the first medical visit was 12.32 months, with an average of 20.57 months from the first visit to diagnosis. The time from first consultation to diagnosis significantly increased with prolonged delay (
conclusionElevated BUN levels are independent predictors of diagnostic delay in CeD, with heterogeneity observed across gender, disease subtype, ethnicity, and pathological type. Clinicians should prioritize high-risk populations with BUN ≥ 4.3 mmol/L, particularly female patients with non-classical CeD and Kazak individuals, to reduce diagnostic delay.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.